Overview

Comparison of GW433908 and Nelfinavir in HIV Patients Who Have Not Had Antiretroviral Therapy

Status:
Unknown status
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
The purpose of this study is to compare GW433908 and nelfinavir when each is given with abacavir and lamivudine to HIV patients who have not taken antiretroviral drugs.
Phase:
Phase 3
Details
Lead Sponsor:
Glaxo Wellcome
Treatments:
Abacavir
Fosamprenavir
Lamivudine
Nelfinavir